Jefferies Starts Cue Biopharma (CUE) at Buy, 'Following Nature's "Cues" W/ Targeted IL-2 Therapy'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: CUE) | Delayed: 18.66 -0.23 (1.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.89 | 52 Week High | $ | |||
| Open | $18.88 | 52 Week Low | $ | |||
| Day High | $19.35 | P/E | N/A | |||
| Day Low | $18.04 | EPS | $ | |||
| Volume | 79,367 | |||||
